/sci/ - Science & Math

>>15441103
relating to your point i want to say this

>riluzole for ALS
>tpa for stroke
>intensive BP control in acute ICH
>tenectaplase for stroke when tpa patent ends
>in general overmedicating and running offbrand cardiology treatments for stroke just to get them big fat bucks $$$
and most recently (and most fucked up of all)
>lecanemab for alzheimer


NEUROLOGY is one of the most captured by pharma specs due to the nature of the disease
it has stroke which is the heart disease of the brain. Huge potential to make big money off lifelong medicating.
devastating chronic diseases for which pharma makes some drug, runs a corporate trial to find a minor clinically insignificant benefit. Than bribes the FDA and boom - standard of care. It is WAAAY more profitable to make a shit drug and bribe the FDA than to actually invest a large sum of money into some experimental new treatment that might work well, but it's risky for the bottom line.

idk if other specialties suffer from the above, I suspect they do. I'd like to hear examples from your specialties